Linda and me, in Egypt
After chemo her hair grew back gray. I really liked it.
Let’s get
the name business over first. Hereafter,
in this essay, he will be known as Dr. T.
Some research this afternoon suggests that the name is Sri Lankan. He received his Ph.D. from Purdue University
and now works at the University of Texas Medical Center in Houston, where he
has been since 1994. He is a co-author
of countless medical research papers (well, 27 since 2000). More about his history I cannot determine.
As an aside,
typing Dr. T’s full name into various search engines is laborious. I can imagine the poor kid in grammar school,
taking exams. The other kids would be
turning in their papers about the time he finished writing his name at the top
of the answer sheet!
But who
cares how tough his name is to spell; he is doing some great work. Partially funded by the Rivkin Center, Dr. T is
developing a novel sort of address label to deliver nanoparticles of
death-dealing drugs directly to cancer cells.
His labels consist of short strands of RNA, especially constructed to
zoom in on specific types of cancer cells and, binding to them, deliver their
lethal load.
This line of
research seems potentially fruitful to me; I have written about nanoparticles before.
However, always remember my abysmal ignorance
of most things biological. If you are
curious, Google “aptamer” and go from there.
Me, I’m still tired from my recent trip.
No comments:
Post a Comment